应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LEXX Lexaria Bioscience Corp
未开盘 07-18 16:00:00 EDT
2.76
-0.12
-4.17%
盘后
2.80
+0.04
+1.45%
18:00 EDT
最高
2.95
最低
2.61
成交量
15.99万
今开
2.80
昨收
2.88
日振幅
11.81%
总市值
4,364万
流通市值
3,778万
总股本
1,581万
成交额
43.95万
换手率
1.17%
流通股本
1,369万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Lexaria Bioscience(LEXX)盘前升2.33% 获新抗病毒药物递送和治疗癫痫专利
金吾财讯 · 07-09
Lexaria Bioscience(LEXX)盘前升2.33% 获新抗病毒药物递送和治疗癫痫专利
加载更多
公司概况
公司名称:
Lexaria Bioscience Corp
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lexaria Bioscience Corp.根据内华达州法律于2004年12月9日成立。该公司是一家生物技术公司,利用获得专利的DehydraTECHTM药物递送技术开发增强广泛的脂溶性活性分子和活性药物成分的生物利用度。DehydraTECH将亲脂性分子或原料药与特定的长链脂肪酸和载体化合物相结合,从而改善它们进入血液的方式,提高其有效性并允许较低的总体剂量,同时促进更健康的口服摄入方法。公司技术可应用于多种治疗适应症,包括高血压和心脏病、糖尿病等。
发行价格:
--
{"stockData":{"symbol":"LEXX","market":"US","secType":"STK","nameCN":"Lexaria Bioscience Corp","latestPrice":2.76,"timestamp":1721332800000,"preClose":2.88,"halted":0,"volume":159936,"hourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.76,"latestTime":"18:00 EDT","volume":570,"amount":1588.7,"timestamp":1721340057850},"delay":0,"floatShares":13689700,"shares":15810205,"eps":-0.462637,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.12,"latestTime":"07-18 16:00:00 EDT","open":2.8,"high":2.95,"low":2.61,"amount":439548.1104,"amplitude":0.118056,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.462637,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721376000000},"adr":0,"adjPreClose":2.88,"preHourTrading":{"tag":"盘前","latestPrice":2.88,"preClose":2.88,"latestTime":"09:15 EDT","volume":862,"amount":2496.8260999999998,"timestamp":1721308537374},"postHourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.76,"latestTime":"18:00 EDT","volume":570,"amount":1588.7,"timestamp":1721340057850},"volumeRatio":1.202083},"requestUrl":"/m/hq/s/LEXX","defaultTab":"news","newsList":[{"id":"2450046175","title":"Lexaria Bioscience(LEXX)盘前升2.33% 获新抗病毒药物递送和治疗癫痫专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2450046175","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450046175?lang=zh_cn&edition=full","pubTime":"2024-07-09 20:03","pubTimestamp":1720526583,"startTime":"0","endTime":"0","summary":"金吾财讯 | Lexaria Bioscience(LEXX)盘前走高,暂升2.33%,报2.64美元。Lexaria获得新的抗病毒药物递送和治疗癫痫的专利。公司是一家尖端的全球性药物分子递送平台创新型企业。Lexaria的专利组合现已增至46项全球授权专利。Lexaria的知识产权仍然是支持未来业务目标的重要组成部分。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277570","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LEXX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexariabioscience.com","stockEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0171},{"period":"3month","weight":0.28},{"period":"6month","weight":0.9592},{"period":"1year","weight":2.6068},{"period":"ytd","weight":1.304}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lexaria Bioscience Corp.根据内华达州法律于2004年12月9日成立。该公司是一家生物技术公司,利用获得专利的DehydraTECHTM药物递送技术开发增强广泛的脂溶性活性分子和活性药物成分的生物利用度。DehydraTECH将亲脂性分子或原料药与特定的长链脂肪酸和载体化合物相结合,从而改善它们进入血液的方式,提高其有效性并允许较低的总体剂量,同时促进更健康的口服摄入方法。公司技术可应用于多种治疗适应症,包括高血压和心脏病、糖尿病等。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.163158},{"month":2,"riseRate":0.5,"avgChangeRate":0.359602},{"month":3,"riseRate":0.25,"avgChangeRate":-0.045608},{"month":4,"riseRate":0,"avgChangeRate":-0.158998},{"month":5,"riseRate":0.5,"avgChangeRate":-0.111675},{"month":6,"riseRate":0.5,"avgChangeRate":0.0757},{"month":7,"riseRate":0.5,"avgChangeRate":-0.006669},{"month":8,"riseRate":0.666667,"avgChangeRate":0.118106},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.071163},{"month":10,"riseRate":0.333333,"avgChangeRate":0.090332},{"month":11,"riseRate":0.666667,"avgChangeRate":0.094181},{"month":12,"riseRate":0,"avgChangeRate":-0.191736}],"exchange":"NASDAQ","name":"Lexaria Bioscience Corp","nameEN":"Lexaria Bioscience Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lexaria Bioscience Corp(LEXX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lexaria Bioscience Corp(LEXX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lexaria Bioscience Corp,LEXX,Lexaria Bioscience Corp股票,Lexaria Bioscience Corp股票老虎,Lexaria Bioscience Corp股票老虎国际,Lexaria Bioscience Corp行情,Lexaria Bioscience Corp股票行情,Lexaria Bioscience Corp股价,Lexaria Bioscience Corp股市,Lexaria Bioscience Corp股票价格,Lexaria Bioscience Corp股票交易,Lexaria Bioscience Corp股票购买,Lexaria Bioscience Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lexaria Bioscience Corp(LEXX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lexaria Bioscience Corp(LEXX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}